-
Sartorius Joins DFKI to Support AI for Advanced Medicines
contractpharma
September 27, 2020
Conducting research on deep learning algorithms for modeling of biological systems and for optimization of biopharmaceutical production processes.
-
AI accelerates drug repurposing to find potential COVID-19 therapies: GlobalData
expresspharma
August 19, 2020
AI start-ups are helping pharma companies to digitally bridge the gap between thousands of repurposed drug molecules, clinical trials and final drug authorization.
-
Scientists leverage AI to find COVID-19 drug candidates
expresspharma
August 14, 2020
They identified the best-in-class hits for the 65 human proteins that interact with SARS-CoV-2 proteins.
-
UCL start-up Novai raises £500,000 for AI tech
pharmatimes
July 24, 2020
Novai, a biotechnology startup out of University College London, has secured £500,000 in seed funding in a round led by SFC Capital.
-
Study is first to identify potential therapeutic targets for COVID-19
worldpharmanews
June 29, 2020
A team from Lawson Health Research Institute and Western University are the first in the world to profile the body's immune response to COVID-19.
-
Artificial Intelligence (AI) Sector is Leveraging Their Technology to Detect Outbreaks, Enable Effective Contact Tracing and Identify Existing Drugs to Treat COVID-19
prnewswire
June 19, 2020
Artificial intelligence is being used in new ways in response to the COVID-19 pandemic. Several companies like BlueDot, IBM and BenevolentAI are leveraging their technologies to detect outbreaks.
-
Researchers develop AI tool able to predict cancer relapse
pharmatimes
May 29, 2020
A team of computer scientists and pathologists have trained an artificial intelligence (AI) tool to identify lung cancer patients who have a higher risk of disease recurrence following treatment.
-
Atomwise leverages AI to explore broad-spectrum Covid-19 drugs
pharmaceutical-technology
May 26, 2020
Atomwise has forged fifteen research collaborations with universities globally to develop broad-spectrum treatments for Covid-19, as well as other coronaviruses.
-
Ultromics, Mayo Clinic Collaborate to Rapidly Assess COVID-19 Patients Using AI
americanpharmaceuticalreview
May 13, 2020
A joint UK-US research team is applying an artificial intelligence system to map for the first time how the COVID-19 virus attacks the heart with such deadly impact.
-
Aberdeen Uni proceeds with COVID-19 mass screening research
pharmatimes
May 07, 2020
Researchers at the University of Aberdeen plan to use artificial intelligence (AI) to try to fast-track a test to allow mass screening for COVID-19, after the £140,000 project was approved by the Scottish government.